{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T12:40:32Z","timestamp":1795178432809,"version":"4.10.3"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:p>\n                    This study investigates the clinical efficacy of liver transplantation (LT) for intrahepatic cholangiocarcinoma (ICC), identifies clinicopathologic factors impacting prognosis, and provides evidence-based data to support LT indications for ICC. A retrospective cohort study was conducted using data from 124 ICC patients in the Chinese Liver Transplant Registry from January 2015 to December 2020. Clinicopathologic data and survival outcomes were analyzed. Postoperative survival was assessed using Kaplan\u2013Meier analysis and Log-rank tests, while Cox regression identified prognostic factors. The number of LT cases for ICC increased yearly from 2015 to 2019, with major centers located in Shanghai, Guangdong, Beijing, Zhejiang, and Hubei. The overall survival (OS) rates at 1, 3, and 5 years were 68.2%, 35.5%, and 32.0%, respectively, and the disease-free survival (DFS) rates were 51.0%, 29.3%, and 26.5%, respectively. Poorer prognosis was linked to male gender, poor Child\u2013Pugh classification, and not meeting the Hangzhou criteria. A significant OS difference was found between 89 male and 35 female patients (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.034), with female patients showing better OS than male patients, but no significant difference was observed in DFS (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.084). Among 78 patients exceeding the Milan criteria, those with preoperative neoadjuvant therapy had better OS (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.041), though DFS differences were not significant (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.228). LT prognosis for ICC is influenced by multiple factors, including worse outcomes for males. Preoperative neoadjuvant therapy improves survival for patients exceeding the Milan criteria but does not significantly prevent recurrence. Optimization of recipient selection and neoadjuvant therapy application is necessary.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044942","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:01:16Z","timestamp":1762210876000},"page":"e44942","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Liver transplantation for intrahepatic cholangiocarcinoma: Insights from a National Registry Study in China"],"prefix":"10.1097","volume":"104","author":[{"given":"Pengcheng","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Surgical Basic Research Laboratory of Liver Cirrhosis and Liver Cancer, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Center of Liver Cancer Diagnosis and Treatment, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Institute of Organ Transplantation, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delin","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Surgical Basic Research Laboratory of Liver Cirrhosis and Liver Cancer, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Center of Liver Cancer Diagnosis and Treatment, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Institute of Organ Transplantation, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Surgical Basic Research Laboratory of Liver Cirrhosis and Liver Cancer, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Center of Liver Cancer Diagnosis and Treatment, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Institute of Organ Transplantation, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjing","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Surgical Basic Research Laboratory of Liver Cirrhosis and Liver Cancer, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Center of Liver Cancer Diagnosis and Treatment, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Institute of Organ Transplantation, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Surgical Basic Research Laboratory of Liver Cirrhosis and Liver Cancer, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Center of Liver Cancer Diagnosis and Treatment, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Institute of Organ Transplantation, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Surgical Basic Research Laboratory of Liver Cirrhosis and Liver Cancer, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Center of Liver Cancer Diagnosis and Treatment, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Institute of Organ Transplantation, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiye","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Surgical Basic Research Laboratory of Liver Cirrhosis and Liver Cancer, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Center of Liver Cancer Diagnosis and Treatment, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Institute of Organ Transplantation, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Surgery Center, Beijing You An Hospital, Clinical Center for Liver Cancer, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[{"name":"China Liver Transplant Registry, Zhejiang University, Hangzhou, China"},{"name":"National Center for Healthcare Quality Management of Liver Transplant, Zhejiang University, Hangzhou, China"},{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China"},{"name":"NHC Key Laboratory of Combined Multi-organ Transplantation, Zhejiang University, Hangzhou, China"},{"name":"Institute of Organ Transplantation, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0512-2835","authenticated-orcid":false,"given":"Zhao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Surgical Basic Research Laboratory of Liver Cirrhosis and Liver Cancer, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Center of Liver Cancer Diagnosis and Treatment, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Peking University Institute of Organ Transplantation, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma.","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","article-title":"Systemic therapies for intrahepatic cholangiocarcinoma.","volume":"72","author":"Kelley","year":"2020","journal-title":"J Hepatol"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/medicina59040729","article-title":"Intrahepatic cholangiocarcinoma-where are we now and where are we going to?","volume":"59","author":"Wasilewicz","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.dld.2023.08.052","article-title":"Intrahepatic cholangiocarcinoma: evolving strategies in management and treatment.","volume":"56","author":"Bragazzi","year":"2024","journal-title":"Dig Liver Dis"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer.","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/cncr.32803","article-title":"Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012.","volume":"126","author":"Florio","year":"2020","journal-title":"Cancer"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ueg2.12154","article-title":"Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland.","volume":"9","author":"Barner-Rasmussen","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis.","volume":"72","author":"Clements","year":"2020","journal-title":"J Hepatol"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.suc.2023.07.006","article-title":"Liver transplant for intrahepatic cholangiocarcinoma.","volume":"104","author":"Eletta","year":"2024","journal-title":"Surg Clin North Am"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","article-title":"Liver resection and transplantation for intrahepatic cholangiocarcinoma.","volume":"72","author":"Mazzaferro","year":"2020","journal-title":"J Hepatol"},{"key":"R11-20260915","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians.","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R12-20260915","first-page":"30","article-title":"Gradual expansion of the indications for minimally invasive liver resection to include highly complex procedures may improve postoperative outcomes.","volume":"8","author":"Yui","year":"2024","journal-title":"Mini-invasive Surgery"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.transproceed.2019.01.156","article-title":"Experience in liver transplantation due to primary sclerosing cholangitis: a single center experience.","volume":"51","author":"Emek","year":"2019","journal-title":"Transplant Proc"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/jlts.2001.29419","article-title":"Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature.","volume":"7","author":"Shimoda","year":"2001","journal-title":"Liver Transpl"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/lt.25780","article-title":"Should we reevaluate liver transplantation as an alternative to resection for the treatment of intrahepatic cholangiocarcinoma?","volume":"26","author":"Panayotova","year":"2020","journal-title":"Liver Transpl"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"553","DOI":"10.14218\/JCTH.2021.00250","article-title":"Neoadjuvant and adjuvant therapy in intrahepatic cholangiocarcinoma.","volume":"10","author":"Chen","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.32258","article-title":"Liver transplantation for intrahepatic cholangiocarcinoma: ready for prime time?","volume":"75","author":"Sapisochin","year":"2022","journal-title":"Hepatology"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jhep.2019.11.017","article-title":"Advances in resection and transplantation for hepatocellular carcinoma.","volume":"72","author":"Vibert","year":"2020","journal-title":"J Hepatol"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/SLA.0000000000000494","article-title":"Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study.","volume":"259","author":"Sapisochin","year":"2014","journal-title":"Ann Surg"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/ajt.16906","article-title":"Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma.","volume":"22","author":"McMillan","year":"2022","journal-title":"Am J Transplant"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment.","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/TP.0000000000003212","article-title":"Liver transplantation for cholangiocarcinoma and mixed hepatocellular cholangiocarcinoma: working group report from the ILTS transplant oncology consensus conference.","volume":"104","author":"Sapisochin","year":"2020","journal-title":"Transplantation"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/TP.0000000000003281","article-title":"Expanding indications of liver transplantation in Spain: consensus statement and recommendations by the Spanish Society of Liver Transplantation.","volume":"105","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2021","journal-title":"Transplantation"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5604\/01.3001.0012.0929","article-title":"Racial, ethnic, and age disparities in incidence and survival of intrahepatic cholangiocarcinoma in the United States; 1995-2014.","volume":"17","author":"Antwi","year":"2018","journal-title":"Ann Hepatol"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1038\/s41598-021-83149-5","article-title":"Clinicopathological characteristics and prognostic factors for intrahepatic cholangiocarcinoma: a population-based study.","volume":"11","author":"Yu","year":"2021","journal-title":"Sci Rep"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"e29910","DOI":"10.1016\/j.heliyon.2024.e29910","article-title":"Sex disparity in clinical characteristics and long-term prognosis after liver resection for patients with intrahepatic cholangiocarcinoma: a propensity score matching analysis.","volume":"10","author":"Zou","year":"2024","journal-title":"Heliyon"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/hep.32198","article-title":"Menopausal hormone therapy and risk of biliary tract cancers.","volume":"75","author":"Jackson","year":"2022","journal-title":"Hepatology"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaoncol.2019.3718","article-title":"Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a phase 2 clinical trial.","volume":"6","author":"Cercek","year":"2020","journal-title":"JAMA Oncol"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jamcollsurg.2010.12.005","article-title":"Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.","volume":"212","author":"Hong","year":"2011","journal-title":"J Am Coll Surg"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1038\/s41598-023-37896-2","article-title":"Liver transplantation for intrahepatic cholangiocarcinoma: a propensity score-matched analysis.","volume":"13","author":"Huang","year":"2023","journal-title":"Sci Rep"},{"issue":"Suppl 2","key":"R32-20260915","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/lt.22365","article-title":"Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.","volume":"17","author":"Mazzaferro","year":"2011","journal-title":"Liver Transpl"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gutjnl-2014-308513","article-title":"Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.","volume":"65","author":"Xu","year":"2016","journal-title":"Gut"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"841694","DOI":"10.3389\/fonc.2021.841694","article-title":"Liver Transplantation for Intrahepatic Cholangiocarcinoma: What Are New Insights and What Should We Follow?","volume":"11","author":"Sun","year":"2021","journal-title":"Front Oncol"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3350\/cmh.2021.0287","article-title":"Intrahepatic cholangiocarcinoma: tumour heterogeneity and its clinical relevance.","volume":"28","author":"Komuta","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/oncolo\/oyac139","article-title":"An expert, multidisciplinary perspective on best practices in biomarker testing in intrahepatic cholangiocarcinoma.","volume":"27","author":"Madoff","year":"2022","journal-title":"Oncologist"},{"key":"R37-20260915","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.31829","article-title":"Genetic determinants of outcome in intrahepatic cholangiocarcinoma.","volume":"74","author":"Boerner","year":"2021","journal-title":"Hepatology"},{"issue":"3 Pt B","key":"R38-20260915","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejso.2020.09.039","article-title":"Cholangiocarcinoma miscoding in hepatobiliary centres.","volume":"47","author":"Selvadurai","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"45576","DOI":"10.1038\/srep45576","article-title":"Plasma apolipoprotein A-V predicts long-term survival in chronic hepatitis B patients with acute-on-chronic liver failure.","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhep.2023.02.027","article-title":"Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.","volume":"79","author":"Lapitz","year":"2023","journal-title":"J Hepatol"},{"key":"R41-20260915","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41698-019-0091-4","article-title":"Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positive refractory cholangiocarcinoma.","volume":"3","author":"Yarlagadda","year":"2019","journal-title":"npj Precis Oncol"},{"key":"R42-20260915","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hbpd.2020.02.008","article-title":"Liver transplantation for intrahepatic and perihilar cholangiocarcinoma: current and future.","volume":"19","author":"Zheng","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:01:01Z","timestamp":1789498861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":42,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044942","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2025-05-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}